Onconex Esophageal Cancer (Germline)

Understanding Onconex Esophageal Cancer (Germline)

Esophageal cancer is the 8th most common cancer worldwide, and the 6th most common cause of cancer related deaths. A majority of esophageal malignancies are either esophageal squamous cell carcinoma (ESCC) or esophageal adenocarcinoma (EAC). Both esophageal squamous cell carcinoma and esophageal adenocarcinoma are aggressive cancers with poor patient response to conventional chemotherapy and radiation treatment.

EGFR amplification and/or overexpression has been detected in a wide variety of ESCC samples, ranging f...

What does Onconex Esophageal Cancer (Germline) measure?

The Onconex Esophageal Cancer (Germline) test is a comprehensive Next Generation Sequencing (NGS) assay for 100 genes associated with esophageal cancer, providing detailed genetic insights to guide targeted therapy and improve patient outcomes.

The Onconex Esophageal Cancer (Germline) test offers a deep understanding of the genetic mutations driving esophageal cancers, such as esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC). NGS technology enables the identification of numerous genetic...